Press Releases

Date	Title	Company
12-Jul-2022	Provepharm receives FDA marketing approval in US for BLUDIGO, its indigo carmine injection drug product	Andrew Lloyd Associates
12-Jul-2022	MODERNA’S OMICRON-CONTAINING BIVALENT BOOSTER CANDIDATE, mRNA-1273.214, DEMONSTRATES SIGNIFICANTLY HIGHER NEUTRALIZING ANTIBODY RESPONSE AGAINST OMICRON SUBVARIANTS BA.4/5 COMPARED TO CURRENTLY AUTHORIZED BOOSTER	MODERNA
12-Jul-2022	Akili Announces Public Company Board of Director Nominees	Akili Interactive
12-Jul-2022	Actigen Receives Positive FDA Response for Rare Disease Treatment	Actigen
12-Jul-2022	Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Completed IVDR Registration	Accelerate Diagnostics
12-Jul-2022	Data presented today show a reduction in treated spontaneous and traumatic bleeds and mean annualised bleeding rate (ABR) of 1.7 with concizumab1	Novo Nordisk
12-Jul-2022	Pivotal data demonstrate once-weekly efanesoctocog alfa provides superior bleed protection compared to prior factor prophylaxis	Sanofi
12-Jul-2022	Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis	Sanofi
12-Jul-2022	AWAKN LIFE SCIENCES RECEIVES UK STATE FUNDING TO IDENTIFY OPTIMAL PATHWAY TO MARKET IN UK & US FOR ITS LEAD CLINICAL DEVELOPMENT PROGRAM – KETAMINE-ASSISTED THERAPY FOR ALCOHOL USE DISORDER	AWAKN LIFE SCIENCES
12-Jul-2022	RevoluGen Wins 2022 BioNewsRound Award for Translational Research	RevoluGen
12-Jul-2022	武田宣佈向東京證券交易所遞交公司治理報告	Businesswire
12-Jul-2022	武田宣布向东京证券交易所提交公司治理报告	Businesswire
12-Jul-2022	Adrenomed appoints David Germonpré as Chief Financial Officer	Adrenomed AG
12-Jul-2022	Drug Screening Market is projected to expand at a 16% CAGR during the forecast period by 2032	MARKITWIRED
12-Jul-2022	Surgical Instruments Tracking System Market is projected to grow at a rate of 15% CAGR during the forecast period by 2032	MARKITWIRED
12-Jul-2022	Self Testing Market is projected to record a CAGR of 5.6% amid the forecast period by 2030	MARKITWIRED
12-Jul-2022	Over-The-Counter Pain Medication Market Is Set to Expand at A CAGR Of 4.1% To Reach US$ 27.7 Billion During the Forecast Period 2022-2028	MARKITWIRED
12-Jul-2022	Orthopaedic Prosthetics Market will witness a CAGR of over 4.5% through 2030	MARKITWIRED
12-Jul-2022	Oral Antiseptics Market Is Set to Expand at A CAGR Of 4.7% To Reach US$ 3.24 Billion During the Forecast Period 2022-2028	MARKITWIRED
12-Jul-2022	Over-the-Counter Pain Medication Market is estimated to attain a valuation of US$ 27.7 Billion by the end of 2028	MARKITWIRED